network member

MD Anderson Cancer Center

1515 Holcombe Blvd., Houston, TX 77030

About Network Member

Website: MD Anderson Cancer Center

https://www.mdanderson.org

Marla J. Polk

Currently Enrolling

HCRN-BRE21-516

BRIDGET: Secondary BRain metastases prevention after Isolated intracranial progression on Trastuzumab/Pertuzumab or T-DM1 in patients with aDvanced human epidermal Growth factor receptor 2+ brEast cancer with the addition of Tucatinib

Cancer areas:Breast

Dana-Farber Cancer Institute

Duke Cancer Institute

MD Anderson Cancer Center

Novant Health Oncology Specialists

Providence Cancer Institute

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

The Ohio State University

UC San Francisco

University of Michigan Rogel Cancer Center

See clinicaltrials.gov

Enrollment Closed

HCRN-LUN18-335

An Open-Label Randomized Phase II Study of Combining Osimertinib with and without Ramucirumab in TKI-naïve EGFR-mutant Locally Advanced or Metastatic NSCLC

Xiuning Le

Cancer areas:Lung

MD Anderson Cancer Center

Moffitt Cancer Center

See clinicaltrials.gov

Enrollment Closed

HCRN-MEL17-309

Phase II single-arm multi-center study of adjuvant ipilimumab in combination with nivolumab in subjects with high-risk ocular melanoma

Suthee Rapisuwon

Cancer areas:Melanoma

Columbia University Irving Medical Center

Georgetown Lombardi Comprehensive Cancer Center

MD Anderson Cancer Center

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

UC San Francisco

See clinicaltrials.gov